Malaria mosquitoes develop resistance to insecticide

Published : Jan 11, 2020 16:04 IST

Researchers at the Liverpool School of Tropical Medicine (LSTM) have identified a new mechanism by which mosquitoes that carry malaria become resistant to insecticides. After studying both Anopheles gambiae and Anopheles coluzzii, two major malaria vectors in West Africa, they found that a particular family of binding proteins situated in the insect’s legs is highly expressed in resistant populations.

Victoria Ingham, the first author of a paper published in the latest issue of “Nature”, said: “We have found a completely new insecticide resistance mechanism that we think is contributing to the lower than expected efficacy of bed nets. The protein, which is based in the legs, comes into direct contact with the insecticide as the insect lands on the net, making it an excellent potential target for future additives to nets to overcome this potent resistance mechanism.”

Examining the Anopheline mosquitoes, the team demonstrated that the binding protein, SAP2, was found elevated in resistant populations and further elevated following contact with pyrethroids, the insecticide used on all bed nets. They found that when levels of this protein were reduced, by partial silencing of the gene, susceptibility to pyrethroids was restored. When the protein was expressed at elevated levels, previously susceptible mosquitoes became resistant to pyrethroids.

The increase in insecticide resistance across mosquito populations has led to the introduction of new insecticide-treated bed nets containing the synergist piperonyl butoxide (PBO) as well as pyrethroid insecticides. However, since mosquitoes continually evolve new resistance mechanisms, the discovery of this new resistance mechanism provides an excellent opportunity to identify additional synergists that could be used to restore susceptibility.

“This newly discovered resistance mechanism could provide us with an important target for both the monitoring of insecticide resistance and the development of novel compounds able to block pyrethroid resistance and prevent the spread of malaria,” said Hilary Ranson, a senior author of the paper.

You have exhausted your free article limit.
Get a free trial and read Frontline FREE for 15 days
Signup and read this article for FREE

Get unlimited access to premium articles, issues, and all-time archives